Wei Du
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research
Papers in
- Surgery 11
- Transplantation: Methods and Outcomes 4
-
- Extracellular vesicles in disease 3
- Co-authors
- Michael S. Simon (4 shared papers)Zongjin Li (9 shared papers)John A. Harvey (4 shared papers)Zhongchao Han (6 shared papers)Na Liu (5 shared papers)Ulka N. Vaishampayan (5 shared papers)Deling Kong (4 shared papers)Qiang Zhao (3 shared papers)
- Journals
- Pediatric Transplantation (4 papers)Cancer (3 papers)Urology (2 papers)Bone Marrow Transplantation (2 papers)Brain Research (2 papers)
- Partner nations
- United StatesChinaFrance
In The Last Decade
Wei Du
75 papers receiving 2.7k citations
Wei Du's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 339
- Oncology 492
- Genetics 138
- Molecular Biology 821
- Pulmonary and Respiratory Medicine 350
Countries citing papers authored by Wei Du
This map shows the geographic impact of Wei Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Du more than expected).
Fields of papers citing papers by Wei Du
This network shows the impact of papers produced by Wei Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Du. The network helps show where Wei Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Wei Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 320 | |
| 2 | 1999 | 268 | |
| 3 | 2017 | 207 | |
| 4 | 2004 | 135 | |
| 5 | Phase II study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma. | 2000 | 107 |
| 6 | 2016 | 100 | |
| 7 | 2003 | 93 | |
| 8 | 2005 | 80 | |
| 9 | 1997 | 71 | |
| 10 | 1997 | 64 | |
| 11 | 1993 | 64 | |
| 12 | 2009 | 59 | |
| 13 | 1997 | 57 | |
| 14 | 1997 | 53 | |
| 15 | 1997 | 52 | |
| 16 | 2009 | 45 | |
| 17 | 2009 | 42 | |
| 18 | 2012 | 41 | |
| 19 | 2015 | 41 | |
| 20 | 2013 | 38 |
About Wei Du
Wei Du is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Physiology, having authored 78 papers that have together received 2.7k indexed citations. Recurring topics across this work include Mechanical Circulatory Support Devices (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Transplantation: Methods and Outcomes (4 papers), Neuroscience and Neuropharmacology Research (3 papers), Electrospun Nanofibers in Biomedical Applications (3 papers), Prostate Cancer Treatment and Research (3 papers), Extracellular vesicles in disease (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (339 citations), Oncology (492 citations), Genetics (138 citations), Molecular Biology (821 citations) and Pulmonary and Respiratory Medicine (350 citations). Wei Du has collaborated with scholars based in United States, China and France. Frequent co-authors include Michael S. Simon, Zongjin Li, John A. Harvey, Zhongchao Han, Na Liu, Ulka N. Vaishampayan, Deling Kong, Qiang Zhao, Vainutis K. Vaitkevicius and Zhibo Han. Their work appears in journals such as Pediatric Transplantation, Cancer, Urology, Bone Marrow Transplantation and Brain Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.